A rare glimpse of the biotechnology ecosystem in the region occurred this week when U.S. Sen. Mark Warner convened many of its tech sector leaders at the Fralin…
With funding from Virginia Catalyst, also known as the Virginia Biosciences Health Research Corp., Virginia Tech is engaged in three collaborative bioscience projects to address unmet health care needs in Virginia, according to Michael Friedlander, vice president for health sciences and technology at Virginia Tech.
Grad student in cardiovascular lab at Fralin Biomedical Research Institute will explore a synthetic molecule as basis for a new therapy to treat arrythmias
Zach Williams thought he'd become a cancer researcher when he joined Virginia Tech's Translational Biology, Medicine, and Health Graduate Program three years ago.